The Food and Drug Administration released an Enterprise Modernization Action Plan (EMAP), the next installment of the agency’s “stronger data and technology foundational approach,” which follows action plans around technology and data modernization. FDA CIO Vid Desai says the plan will accelerate operational efficiency, data use and cross-agency alignment. Desai dives into FDA’s requested fiscal year 2023 budget and what it means for continued modernization across the agency.